Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer

Journal of Clinical Oncology

Volumn 32, Issue 33, 2014, Pages 3716-3722

  Jacobs, Eric J ^a   Newton, Christina C ^a   Stevens, Victoria L ^a   Campbell, Peter T ^a   Freedland, Stephen J ^b   Gapstur, Susan M ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG INFORMATION; DRUG USE; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONMETASTATIC PROSTATE CANCER; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; COHORT ANALYSIS; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASPIRIN; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84911895647     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.8875     Document Type: Article

References (19)

1. Eggener SE, Scardino PT, Walsh PC, et al: Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 185:869-875, 2011
2. Thun MJ, Jacobs EJ, Patrono C: The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9:259-267, 2012
3. Patrono C, Garcia Rodriguez LA, Landolfi R, et al: Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353:2373-2383, 2005
4. Patrono C, Coller B, FitzGerald GA, et al: Platelet-active drugs: The relationships among dose, effectiveness, and side effects-The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:234S-264S, 2004
5. Rao GH, Fareed J: Aspirin prophylaxis for the prevention of thrombosis: Expectations and limitations. Thrombosis 2012:104707, 2012
6. Gay LJ, Felding-Habermann B: Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123-134, 2011
7. Goubran HA, Burnouf T, Radosevic M, et al: The platelet-cancer loop. Eur J Intern Med 24:393-400, 2013
8. Choe KS, Cowan JE, Chan JM, et al: Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol 30:3540-3544, 2012
9. Dhillon PK, Kenfield SA, Stampfer MJ, et al: Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila) 5:1223-1228, 2012
10. Choe KS, Correa D, Jani AB, et al: The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer 116:1820-1826, 2010
11. Zaorsky NG, Buyyounouski MK, Li T, et al: Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys 84:e13-e17, 2012
12. Flahavan EM, Bennett K, Sharp L, et al: A cohort study investigating aspirin use and survival in men with prostate cancer. Ann Oncol 25:154-159, 2014
13. Algra AM, Rothwell PM: Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13:518-527, 2012
14. Calle EE, Rodriguez C, Jacobs EJ, et al: The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer 94:2490-2501, 2002
15. Willard JE, Lange RA, Hillis LD: The use of aspirin in ischemic heart disease. N Engl J Med 327:175-181, 1992
16. Calle EE, Terrell DD: Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 137:235-241, 1993
17. Mohler J, Bahnson RR, Boston B, et al: NCCN clinical practice guidelines in oncology: Prostate cancer. J Natl Compr Canc Netw 8:162-200, 2010
18. Cardwell CR, Flahavan EM, Hughes CM, et al: Low-dose aspirin and survival in men with prostate cancer: A study using the UK Clinical Practice Research Datalink. Cancer Causes Control 25:33-43, 2014
19. Phillips I, Langley R, Gilbert D, et al: Aspirin as a treatment for cancer. Clin Oncol (R Coll Radiol) 25:333-335, 2013